|
🐜
|
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.
7 auth.
L. R. Lard,
H. Visser,
I. Speyer,
I. E. V. Horst-Bruinsma,
A. Zwinderman,
F. Breedveld,
...
J. Hazes
|
9 |
2001 |
9
🐜
|
|
🐜
|
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
13 auth.
H. van Dongen,
J. van Aken,
L. R. Lard,
K. Visser,
H. K. Ronday,
H. Hulsmans,
I. Speyer,
M. Westedt,
A. Peeters,
C. Allaart,
...
R. Toes,
F. C. Breedveld,
Tom W. J. Huizinga
|
8 |
2007 |
8
🐜
|
|
🐬
|
Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial
J. Fransen,
H. Moens,
I. Speyer,
P. Riel
|
7 |
2005 |
7
🐬
|
|
🐬
|
Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care.
I. E. V. Horst-Bruinsma,
I. Speyer,
H. Visser,
F. Breedveld,
J. Hazes
|
7 |
1998 |
7
🐬
|
|
🐜
|
DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis
11 auth.
Y. Goekoop-Ruiterman,
J. D. de Vries-Bouwstra,
P. Kerstens,
M. Nielen,
K. Vos,
D. van Schaardenburg,
...
I. Speyer,
P. Seys,
F. Breedveld,
C. Allaart,
B. Dijkmans
|
7 |
2009 |
7
🐜
|
|
🐜
|
Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors
8 auth.
H. Visser,
K. Vos,
E. Zanelli,
W. Verduyn,
G. Schreuder,
I. Speyer,
...
F. Breedveld,
J. Hazes
|
7 |
2002 |
7
🐜
|
|
🐜
|
A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study
13 auth.
L. Heimans,
K. W. Boer,
K. Visser,
R. Goekoop,
M. Oosterhout,
J. Harbers,
C. Bijkerk,
I. Speyer,
M. D. Buck,
P. Sonnaville,
...
B. Grillet,
T. Huizinga,
C. Allaart
|
6 |
2013 |
6
🐜
|
|
🐜
|
Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial
12 auth.
N. B. Klarenbeek,
S. M. van der Kooij,
T. Huizinga,
Y. Goekoop-Ruiterman,
H. Hulsmans,
M. V. van Krugten,
...
I. Speyer,
J. D. de Vries-Bouwstra,
P. Kerstens,
T. Huizinga,
B. Dijkmans,
C. Allaart
|
6 |
2010 |
6
🐜
|
|
🐜
|
Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)
12 auth.
Y. Goekoop-Ruiterman,
J. D. de Vries-Bouwstra,
C. Allaart,
P. Kerstens,
B. Grillet,
M. D. de Jager,
...
K. Han,
I. Speyer,
P. A. van der Lubbe,
P. Seys,
F. Breedveld,
B. Dijkmans
|
6 |
2007 |
6
🐜
|
|
🐜
|
Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment
19 auth.
I. Markusse,
G. Akdemir,
L. Dirven,
Y. Goekoop-Ruiterman,
J. van Groenendael,
K. H. Han,
T. Molenaar,
S. le Cessie,
W. F. Lems,
P. A. van der Lubbe,
...
P. Kerstens,
André J. Peeters,
H. K. Ronday,
P. D. de Sonnaville,
I. Speyer,
T. Stijnen,
S. ten Wolde,
T. Huizinga,
C. Allaart
|
5 |
2016 |
5
🐜
|
|
🐜
|
Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study)
10 auth.
Jill van Aken,
L. Heimans,
H. V. Dongen,
K. Visser,
H. Ronday,
I. Speyer,
...
A. Peeters,
T. Huizinga,
C. Allaart,
T. K. Kvien
|
5 |
2013 |
5
🐜
|
